Affiliation:
1. Institute of Neuroscience College of Medicine Xiamen University Xiamen Fujian 361105 China
2. Department of Anesthesiology First Affiliated Hospital College of Medicine Xiamen University Xiamen Fujian 361105 China
3. Shanghai Mental Health Center Shanghai Jiaotong University School of Medicine Shanghai 200030 China
4. The Key Laboratory of Neural and Vascular Biology Ministry of Education College of Basic Medicine Hebei Medical University Shijiazhuang 050017 China
Abstract
AbstractFOXG1 syndrome is a developmental encephalopathy caused by FOXG1 (Forkhead box G1) mutations, resulting in high phenotypic variability. However, the upstream transcriptional regulation of Foxg1 expression remains unclear. This report demonstrates that both deficiency and overexpression of Men1 (protein: menin, a pathogenic gene of MEN1 syndrome known as multiple endocrine neoplasia type 1) lead to autism‐like behaviors, such as social defects, increased repetitive behaviors, and cognitive impairments. Multifaceted transcriptome analyses revealed that Foxg1 signaling is predominantly altered in Men1 deficiency mice, through its regulation of the Alpha Thalassemia/Mental Retardation Syndrome X‐Linked (Atrx) factor. Atrx recruits menin to bind to the transcriptional start region of Foxg1 and mediates the regulation of Foxg1 expression by H3K4me3 (Trimethylation of histone H3 lysine 4) modification. The deficits observed in menin deficient mice are rescued by the over‐expression of Foxg1, leading to normalized spine growth and restoration of hippocampal synaptic plasticity. These findings suggest that menin may have a putative role in the maintenance of Foxg1 expression, highlighting menin signaling as a potential therapeutic target for Foxg1‐related encephalopathy.
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
China Postdoctoral Science Foundation